<DOC>
	<DOC>NCT01281215</DOC>
	<brief_summary>The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.</brief_summary>
	<brief_title>Education Interventions Model for Rational Drug Use (RDU)</brief_title>
	<detailed_description>Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.</detailed_description>
	<criteria>Subject with asthma diagnosed according to criteria of the Global Strategy for Asthma Management and Prevention; Subject is a male or female with 18 to 73 yearsold; Subject who has access to medications supplied by the the Brazil Heath Care System; Subject unable to perform the procedures or conditions such as pregnancy that may affect the results of the study; Literate subject without Cognitive Disorders, Alzheimer's, Dementia, that can limit the ability to participate in this study; Subject who have availability to attend the monthly meetings; Subject provides written informed consent and attend the first evaluation. Subject who cannot be classified in the inclusion criteria.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Pharmaceutical Education</keyword>
	<keyword>Rational Drug Use</keyword>
	<keyword>Asthma</keyword>
</DOC>